Verrica Announces Pricing of Public Offering of Common Stock
WEST CHESTER, Pa., June 29, 2022 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (NASDAQ: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the pricing of its underwritten public offering of 12,000,000 shares of its common stock at a price to the public of $2.10 per share.
- WEST CHESTER, Pa., June 29, 2022 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (NASDAQ: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the pricing of its underwritten public offering of 12,000,000 shares of its common stock at a price to the public of $2.10 per share.
- In addition, Verrica has granted to the underwriter a 30-day option to purchase up to 1,800,000 additional shares of common stock at the public offering price, less the underwriting discount.
- The gross proceeds from the offering to Verrica are expected to be approximately $25.2 million, before deducting underwriting discounts and commissions and offering expenses, but excluding any exercise of the underwriters option.
- However, while Verrica may elect to update these forward-looking statements at some point in the future, Verrica specifically disclaims any obligation to do so.